Deutsche Bank Aktiengesellschaft »

Aeglea Biotherapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-12-31 $731k 31k 23.28
2024-09-30 $633k 22k 29.41
2024-06-30 $382k 16k 23.51
2024-03-31 $11k 298 37.93